bladder cancer therapeutics (New York University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebladder cancer therapeutics (New York University)

Drug Alias Nameantibodies (New York University)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodiesBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsUrinary Bladder Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNew York University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNew York University

Active IndicationsN/A

Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A